NET SALES - Disaggregation of Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Total net sales	$ 15,113	$ 12,784	$ 11,673
U.S.
Disaggregation of Revenue [Line Items]
Total net sales	7,223	5,180	4,878
International
Disaggregation of Revenue [Line Items]
Total net sales	7,890	7,604	6,795
Renal Care
Disaggregation of Revenue [Line Items]
Total net sales	3,748	3,900	3,757
Renal Care \| U.S.
Disaggregation of Revenue [Line Items]
Total net sales	945	890	848
Renal Care \| International
Disaggregation of Revenue [Line Items]
Total net sales	2,803	3,010	2,909
Medication Delivery
Disaggregation of Revenue [Line Items]
Total net sales	2,886	2,880	2,691
Medication Delivery \| U.S.
Disaggregation of Revenue [Line Items]
Total net sales	1,889	1,859	1,738
Medication Delivery \| International
Disaggregation of Revenue [Line Items]
Total net sales	997	1,021	953
Pharmaceuticals
Disaggregation of Revenue [Line Items]
Total net sales	2,126	2,291	2,098
Pharmaceuticals \| U.S.
Disaggregation of Revenue [Line Items]
Total net sales	682	753	849
Pharmaceuticals \| International
Disaggregation of Revenue [Line Items]
Total net sales	1,444	1,538	1,249
Clinical Nutrition
Disaggregation of Revenue [Line Items]
Total net sales	931	964	910
Clinical Nutrition \| U.S.
Disaggregation of Revenue [Line Items]
Total net sales	352	343	330
Clinical Nutrition \| International
Disaggregation of Revenue [Line Items]
Total net sales	579	621	580
Advanced Surgery
Disaggregation of Revenue [Line Items]
Total net sales	998	977	886
Advanced Surgery \| U.S.
Disaggregation of Revenue [Line Items]
Total net sales	574	545	516
Advanced Surgery \| International
Disaggregation of Revenue [Line Items]
Total net sales	424	432	370
Acute Therapies
Disaggregation of Revenue [Line Items]
Total net sales	701	782	740
Acute Therapies \| U.S.
Disaggregation of Revenue [Line Items]
Total net sales	241	287	286
Acute Therapies \| International
Disaggregation of Revenue [Line Items]
Total net sales	460	495	454
BioPharma Solutions
Disaggregation of Revenue [Line Items]
Total net sales	644	669	486
BioPharma Solutions \| U.S.
Disaggregation of Revenue [Line Items]
Total net sales	305	273	234
BioPharma Solutions \| International
Disaggregation of Revenue [Line Items]
Total net sales	339	396	252
Patient support systems
Disaggregation of Revenue [Line Items]
Total net sales	1,487	115	0
Patient support systems \| U.S.
Disaggregation of Revenue [Line Items]
Total net sales	1,150	86	0
Patient support systems \| International
Disaggregation of Revenue [Line Items]
Total net sales	337	29	0
Front line care
Disaggregation of Revenue [Line Items]
Total net sales	1,148	70	0
Front line care \| U.S.
Disaggregation of Revenue [Line Items]
Total net sales	840	51	0
Front line care \| International
Disaggregation of Revenue [Line Items]
Total net sales	308	19	0
Surgical solutions
Disaggregation of Revenue [Line Items]
Total net sales	304	27	0
Surgical solutions \| U.S.
Disaggregation of Revenue [Line Items]
Total net sales	145	12	0
Surgical solutions \| International
Disaggregation of Revenue [Line Items]
Total net sales	159	15	0
Other
Disaggregation of Revenue [Line Items]
Total net sales	140	109	105
Other \| U.S.
Disaggregation of Revenue [Line Items]
Total net sales	100	81	77
Other \| International
Disaggregation of Revenue [Line Items]
Total net sales	$ 40	$ 28	$ 28